Cellectar Biosciences, Inc. (CLRB)

Cellectar Biosciences Market Cap

Cellectar Biosciences has a market cap or net worth of $19.58 million as of June 16, 2026. Its market cap has increased by 61.82% in one year.

• Market Cap: 19.58M
• Enterprise Value: 12.76M
• 1-Year Change: 61.82%
• Ranking: #5028
• Category: Nano-Cap
• Stock Price: $2.45

Market Cap Chart

Since November 10, 2005, Cellectar Biosciences's market cap has increased from $7.50M to $19.58M, an increase of 161.07%. That is a compound annual growth rate of 4.77%.

Market Cap History

Date	Market Cap	% Change
Jun 16, 2026	19.58M	56.64%
Dec 31, 2025	12.50M	1.63%
Dec 31, 2024	12.30M	-63.82%
Dec 29, 2023	34.00M	112.50%
Dec 30, 2022	16.00M	-60.59%
Dec 31, 2021	40.60M	-27.24%
Dec 31, 2020	55.80M	164.45%
Dec 31, 2019	21.10M	185.14%
Dec 31, 2018	7.40M	-65.90%
Dec 29, 2017	21.70M	233.85%
Dec 30, 2016	6.50M	3.17%
Dec 31, 2015	6.30M	-73.08%
Dec 31, 2014	23.40M	9.86%
Dec 31, 2013	21.30M	-37.72%
Dec 31, 2012	34.20M	187.39%
Dec 30, 2011	11.90M	325.00%
Dec 31, 2010	2.80M	-98.80%
Dec 31, 2009	233.20M	2,164.08%
Dec 31, 2008	10.30M	-56.90%
Dec 31, 2007	23.90M	-22.90%
Dec 29, 2006	31.00M	-30.49%
Dec 30, 2005	44.60M	494.67%
Nov 10, 2005	7.50M	-

View and export this data all the way back to 2005. Sign Up Today.

Data Source: Nasdaq Data Link Last updated: Jun 15, 2026

Market cap data is provided by Nasdaq Data Link. The current market cap updates continuously throughout the trading day, while the historical market cap is updated daily after market close.

Update frequency:

Daily

Last checked:

Jun 16, 2026

Data Sources Report a data error

Related Stocks

Company	Market Cap
Traws Pharma	19.39M
AEON Biopharma	18.81M
Passage Bio	18.64M
Lipocine	18.63M
Werewolf Therapeutics	18.52M
Tempest Therapeutics	18.07M
Exicure	17.72M
Sensei Biotherapeutics	17.45M